Grace Hwang
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations.
Across 52 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$124
- Novo Nordisk$115
- Bayer$69
- Amneal Pharmaceuticals LLC$68
- Sanofi-aventis U.S. LLC$59
- Sequel Med Tech, LLC$45
- plus $532 from 21 others
What the payments were for
- Food & beverage$1,012100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 6 | $124 |
| Novo Nordisk | 6 | $115 |
| Bayer | 3 | $69 |
| Amneal Pharmaceuticals LLC | 4 | $68 |
| Sanofi-aventis U.S. LLC | 3 | $59 |
| Sequel Med Tech, LLC | 2 | $45 |
| Mannkind Corporation | 2 | $43 |
| Boehringer Ingelheim | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $41 |
| Corcept Therapeutics | 2 | $36 |
| Medtronic | 2 | $36 |
| Tolmar, Inc. | 2 | $34 |
| Amgen | 2 | $32 |
| Sandoz | 2 | $30 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| Antares Pharma, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Abbott | 1 | $18 |
| Vivus LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| GSK | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$1,012 in reported general payments places this provider in the 70th percentile of 4,522 family providers in North Carolina.
Other family in Cary
- Amanda KellyCary$94K
- Daria LewisCary$66K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.